Pfizer and Amgen both grew revenue last quarter at nearly the same pace, but the engines driving that growth point toward two very different futures in oncology. One company is collecting cash from proven assets while the other races to rebuild before its foundation erodes further.
Detailed price information for Pfizer Inc (PFE-N) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.